Automate eCOA Migration with GlobalLink XCompare

Reduce eCOA migration errors by 97% with XCompare technology that automates your development and migration workflows.

Schedule a Demo
COA Migration

Faster Migration, Fully Compliant

XCompare’s automated development and translation workflows help clinical teams accelerate COA migrations while significantly reducing errors.

  • Control eCOA language quality during development
  • Guarantee accuracy of translated eCOA content for adapted and existing text
  • Export fully auditable and controlled reports
  • Use any file type
  • Reduce project delays
  • Reduce rounds of screenshot reviews

Mitigate eCOA Migration Risk without Delaying Your Study

As life sciences companies transition from traditional COA administration to electronic processes, TransPerfect’s GlobalLink XCompare™ technology straightens the path for eCOA adaptation and COA migration. Streamline your COA migration and mitigate risk with eCOA automation. Our proprietary solution makes ensuring accuracy and compliance of eCOA content easier and faster for your clinical team.

Manual Migration vs. XCompare Technology

Human-Led Migration

✘ Traditional migration methods include several lengthy manual processes, including manual copy/paste and manual reviews, which are prone to error.

XCompare Technology

✓ GlobalLink XCompare automates manual migration processes, reduces errors by 97%, and speeds up eCOA migration timelines by 50%.

Manual Paper Comparison Key

Create a manual source key to identify all the similarities and differences between pen/paper to the electronic version.

Automated Migration

GlobalLink XCompare uses artificial intelligence (AI) to detect changes between paper and electronic versions and present them in a user-friendly report.

Manual Migration Process

Copy and paste the text manually into an electronic format while trying to implement adaptations.

Subject matter experts are required to do a manual review of every word, making it hard to identify slight deviations.

Automatic Track Changes

All changes are tracked in a comprehensive log for easy scanning, review, error identification, and decision-making.

Manual Quality Control

Relies on tedious, error-prone manual quality control checks across multiple versions of your documents and source key.

Consistent and Objective Quality Control

GlobalLink XCompare detects changes between the proposed target content and the approved paper versions, automatically flagging errors in the electronic translation when no discrepancies are present in the electronic source.

Trusted by Life Sciences Organizations Big and Small

Join TransPerfect's community of more than 1,000 life sciences organizations, including pharma, biotech, CROs, IRBs, and agencies.

Biogen
Evidera/PPD
untitled_design_3.png
AstraZeneca

eCOA Migration Automation by the Numbers


97 %

Reduction in migration errors

50 %

Reduction in review rounds

2.5 x

Decrease in screenshot compare time

globallinklogo

GlobalLink is the world’s most flexible translation management system. Since its introduction in 1999, TransPerfect’s GlobalLink translation management technology has helped many of the world’s leading life sciences organizations simplify the process of creating, releasing, and managing multilingual content.

News and Thought Leadership

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations involved in clinical trial management.

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects today’s eCOA capabilities or institutional habit. Paper is often framed as the “gold standard,” yet paper-based patient-reported outcome data can be incomplete, error-prone and difficult to ...

XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

Top 10 Pharma Company Overhauls Global COA Program,Cutting Costs by 33% and Errors to Near Zero

Inconsistent standards, stretched timelines, and limited visibility were straining a top 10 pharma company's COA program. Discover how TransPerfect Life Sciences' centralization strategy delivered 99.7% accuracy, 40% less PM oversight, and 33% cost savings across the ...

Four Years In: What the EU Clinical Trial Regulation Has (and Hasn't) Delivered

When the EU Clinical Trial Regulation (EU CTR No 536/2014) went live for new submissions on January 31, 2022, it promised to transform how clinical trials are authorized and conducted across Europe: a single submission, one decision, and harmonized oversight. Four years in,...

How to Make Your Academy Succeed at Global Scale—Lessons Learned on What Works and What Doesn’t

Most life sciences and MedTech companies launch a corporate academy with strong strategic intent, whether that’s executive sponsorship, a named platform, a dedicated budget, or a curriculum mapped to business goals. After launch, however, these same organizations all too often ...

IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays

Investigational medicinal product (IMP) labeling sits at the heart of clinical trial supply, impacting departments across pharmaceutical organizations, from clinical operations and regulatory affairs to quality assurance and beyond. When labeling activities are managed across ...

The Missing Link: Why Study Design Makes or Breaks a Clinical Trial

In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant at OptiTrial, to explore why study design is so often the overlooked "missing link" in clinical ...

C3 Summit 2026 - London

Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to ...

Are you launching a study with eCOA?

Now is the right time to engage with us. Our AI-powered eCOA migration automation reduces risk of errors by 97%, supports lean turnaround times, and delivers a fully compliant paper scale digitization. Talk with our experts about migrating your paper COAs with accuracy, timeliness, and compliance.

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.